Veraxa Biotech AG Ord Shs

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Veraxa Biotech AG Ord Shs had 32.79K in cash and cash equivalents.

Veraxa Biotech AG Ord Shs reported 13.34M in total liabilities as of the latest reported quarter, including 1.29M in current liabilities and 12.04M in non-current liabilities.

As of the latest reported quarter, Veraxa Biotech AG Ord Shs's total assets were 270.06M, consisting of 193.64K in current assets and 269.86M in non-current assets.

Veraxa Biotech AG Ord Shs reported 256.72M in total shareholders' equity as of the latest reported quarter.